Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statements of Operations

v3.25.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Research and development $ 3,020,563 $ 4,846,156 $ 12,669,495 $ 9,489,848
Selling, general and administrative 5,010,528 5,809,325 15,402,074 18,364,622
Total operating expenses 8,031,091 10,655,481 28,071,569 27,854,470
Gain on sale of ENTADFI® assets 484,615 110,000 2,154,134 1,028,372
Operating loss from continuing operations (7,546,476) (10,545,481) (25,917,435) (26,826,098)
Non-operating income (expenses):        
Gain on extinguishment of debt 0 0 8,624,778 0
Change in fair value of equity securities 0 (117,620) (349,078) (689,548)
Other income, net 223,375 323,045 656,338 805,109
Total non-operating income 223,375 205,425 8,932,038 115,561
Net loss from continuing operations (7,323,101) (10,340,056) (16,985,397) (26,710,537)
Net loss from discontinued operations, net of taxes (9,719) (628,818) (7,194,389) (2,560,266)
Net income (loss) $ (7,332,820) $ (10,968,874) $ (24,179,786) $ (29,270,803)
Net loss from continuing operations per basic and diluted common shares outstanding (in dollars per share) $ (0.5) $ (0.71) $ (1.16) $ (2.04)
Net loss from discontinued operations per basic and diluted common shares outstanding (in dollars per share) (0) (0.04) (0.49) (0.2)
Net loss per basic and diluted common shares outstanding (in dollars per share) $ (0.5) $ (0.75) $ (1.65) $ (2.23)
Basic and diluted weighted average common shares outstanding (in shares) 14,657,777 14,638,317 14,644,927 13,101,071